Seneschal Advisors’s DexCom DXCM Stock Holding History

Seneschal Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$314	Buy	5 +3	+150%	+$209	﹤0.01%	468
2025 Q4	$133	Sell	2 -1	-33%	-$65	﹤0.01%	560
2025 Q3	$202	Buy	+3	New	+$237	﹤0.01%	533

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Seneschal Advisors's DXCM Position: Q1 2026 in Review

Seneschal Advisors increased its DexCom (DXCM) stake by 150% in Q1 2026, buying an estimated $209 and bringing the position to 5 shares worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #468.

Seneschal Advisors first reported a position in DXCM in Q3 2025 and has held it in 3 quarters since. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Seneschal Advisors held 5 shares of DexCom worth $314 as of Q1 2026.
Seneschal Advisors bought 3 DexCom shares in Q1 2026, an estimated $209.
DexCom made up ﹤0.01% of Seneschal Advisors's portfolio in Q1 2026, its #468 holding.
Seneschal Advisors first reported a position in DexCom in Q3 2025 and has held it in 3 quarters since.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Seneschal Advisors's 13F filing for Q1 2026, filed 8 May 2026.